4.5 Editorial Material

BLADDER CANCER Pioglitazone-when is a prescription drug safe?

期刊

NATURE REVIEWS UROLOGY
卷 12, 期 12, 页码 655-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrurol.2015.237

关键词

-

资金

  1. National Institute for Health Research [ACF-2014-15-001] Funding Source: researchfish

向作者/读者索取更多资源

In a recent issue of JAMA, Lewis et al. present long-term data on the likelihood of a link between pioglitazone and the risk of bladder cancer and ten other cancers. Their findings contradict previous concerns regarding the safety of pioglitazone, and add to the controversy surrounding interpretation of rare adverse events associated with prescription drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据